The majority of cancers exhibit deregulated expression of MYC as a result of either activation of upstream regulatory signals, such as WNT-dependent MYC expression [68] and Src-dependent MYC activation [69], or chromosomal instability, which causes gene amplification, insertional mutagenesis, and gene translocation [70,71,72]. Here, MYC is linked to cancer.